BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

United Kingdom Intellectual Property Office Decisions
You are here: BAILII >> Databases >> United Kingdom Intellectual Property Office Decisions >> Mr. A.M.H.S. El -Tawil (Patent) [2011] UKIntelP o27211 (5 August 2011)
URL: http://www.bailii.org/uk/cases/UKIntelP/2011/o27211.html
Cite as: [2011] UKIntelP o27211

[New search] [Printable PDF version] [Help]

Mr. A.M.H.S. El-Tawil [2011] UKIntelP o27211 (5 August 2011)

For the whole decision click here: o27211

Patent decision

BL number
O/272/11
Concerning rights in
GB0611402.9
Hearing Officer
Mr S Brown
Decision date
5 August 2011
Person(s) or Company(s) involved
Mr. A.M.H.S. El-Tawil
Provisions discussed
PA 1977 sections 1(1) and 14(5)(c)
Keywords
Inventive step, Novelty
Related Decisions
None

Summary

The application concerns the use of zinc in the treatment of inflammatory bowel diseases. The Hearing Officer followed the guidance in Prendergast's Applications and concluded that the claims lacked the required level of support. The Hearing Officer also compared the treatment with that in two citations and found that the claims also lacked the required novelty and inventive step. The application was refused.


BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/cases/UKIntelP/2011/o27211.html